These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20587143)

  • 1. Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia.
    Cobellis G; Maione C; Botti C; Coppola A; Silvestroni A; Lillo S; Schiavone V; Molinari AM; Sica V
    Cell Transplant; 2010; 19(11):1425-37. PubMed ID: 20587143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
    Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
    Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The salvage of ischaemic limb by therapeutical angiogenesis].
    Talapková R; Hudecek J; Sinák I; Kubisz P; Laca L; Hlinka L; Zelenák K
    Vnitr Lek; 2009 Mar; 55(3):179-83. PubMed ID: 19378842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous bone marrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia].
    Boda Z; Veréb Z; Rajnavölgyi E
    Orv Hetil; 2006 Jun; 147(25):1155-60. PubMed ID: 16893130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
    Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
    Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic angiogenesis in the management of critical limb ischemia: current concepts and review.
    Attanasio S; Snell J
    Cardiol Rev; 2009; 17(3):115-20. PubMed ID: 19384084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
    Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
    Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
    Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
    Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.
    Maione C; Botti C; Coppola CA; Silvestroni C; Lillo S; Schiavone V; Sica G; Sica V; Kumar V; Cobellis G
    Transplant Proc; 2013; 45(1):402-6. PubMed ID: 23375329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs.
    Jiang M; Wang B; Wang C; He B; Fan H; Guo TB; Shao Q; Gao L; Liu Y
    J Cell Biochem; 2008 Jan; 103(1):321-34. PubMed ID: 17541946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease.
    Cobellis G; Silvestroni A; Lillo S; Sica G; Botti C; Maione C; Schiavone V; Rocco S; Brando G; Sica V
    Bone Marrow Transplant; 2008 Nov; 42(10):667-72. PubMed ID: 18695661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic angiogenesis for peripheral arterial disease and ischemic heart disease by autologous bone marrow cells implantation].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Nov; 64(11):2126-34. PubMed ID: 17087307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.
    Kinnaird T; Stabile E; Burnett MS; Lee CW; Barr S; Fuchs S; Epstein SE
    Circ Res; 2004 Mar; 94(5):678-85. PubMed ID: 14739163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
    Perin EC; Silva G; Gahremanpour A; Canales J; Zheng Y; Cabreira-Hansen MG; Mendelsohn F; Chronos N; Haley R; Willerson JT; Annex BH
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1060-7. PubMed ID: 21594960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization.
    Coppolino G; Buemi A; Bolignano D; Lacquaniti A; La Spada M; Stilo F; De Caridi G; Benedetto F; Loddo S; Buemi M; Spinelli F
    J Surg Res; 2009 Nov; 157(1):e129-35. PubMed ID: 19589539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia.
    Di Stefano R; Barsotti MC; Melillo E; Iorio M; Santoni T; Armani C; Dell'omodarme M; Ristori C; De Caterina R; Balbarini A
    Thromb Haemost; 2008 Nov; 100(5):871-7. PubMed ID: 18989532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells].
    Di Stefano R; Limbruno U; Barone D; Balbarini A
    Ital Heart J Suppl; 2004 Jan; 5(1):1-13. PubMed ID: 15253139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.